Myriad Genetics to Present Seven Studies at the 2019 National Society of Genetic Counselors Annual Meeting

Ads

You May Also Like

Biocartis Group NV: Results of the extraordinary shareholders’ meeting held on 11 September 2017

PRESS RELEASE: REGULATED INFORMATION11 September 2017, 17:40 CEST                                                            Results of the extraordinary shareholders' meeting ...

SAGE Updates Guidance for Top-Line Results of Phase 3 STATUS Trial of SAGE-547

CAMBRIDGE, Mass., Dec. 15, 2015 (GLOBE NEWSWIRE) -- Sage Therapeutics (NASDAQ:SAGE) today announced updated guidance ...